Eli Lilly and Company logo

Eli Lilly and Company LLY

$ 1 045.74 -1.17%

Quarterly report 2025-Q2
added 08-07-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

901 M

Market Cap[1]

$ 942 B

EBITDA (LTM)

$ 2.37 B

P/E (LTM)

76.11

P/S (LTM)

18.46

EPS (LTM)

13.74

Eli Lilly and Company is one of the world's largest pharmaceutical companies, specializing in the development, manufacturing, and sale of innovative drugs for the treatment of various diseases.

The company was founded in 1876 in Indianapolis, Indiana and has since become a leader in the pharmaceutical industry. Eli Lilly and Company develops and manufactures a wide range of drugs, including those for diabetes, cancer, mental disorders, Alzheimer's disease, and other illnesses.

One of the company's most well-known developments is insulin, which was created in 1923. This drug became the first effective treatment for diabetes and has saved millions of lives worldwide.

Eli Lilly and Company actively invests in research and development of new drugs to help patients worldwide fight various diseases. The company also aims to improve the quality of life for patients by providing them with access to high-quality drugs. Is a global company with operations in more than 125 countries. The company cares about its employees and society as a whole, participating in various charitable projects and social responsibility programs.

Overall, is one of the most successful and innovative companies in the pharmaceutical industry. Its products help millions of people worldwide overcome difficulties associated with various diseases and improve their quality of life.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
AC Immune SA AC Immune SA
ACIU
$ 2.8 2.19 % $ 229 M Nasdaq Global Market schweizSchweiz
ADiTx Therapeutics ADiTx Therapeutics
ADTX
$ 2.49 -11.39 % $ 32.8 K Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Abeona Therapeutics Abeona Therapeutics
ABEO
$ 4.59 -4.08 % $ 98.1 M Nasdaq Capital Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
$ 12.12 -1.58 % $ 3.74 B NYSE usaUSA
Axcella Health Axcella Health
AXLA
- -16.42 % $ 249 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Armata Pharmaceuticals Armata Pharmaceuticals
ARMP
$ 5.37 -20.68 % $ 194 M NYSE American usaUSA
Atreca Atreca
BCEL
- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
argenx SE argenx SE
ARGX
$ 919.62 2.76 % $ 25 B Nasdaq Global Select Market niderlandNiderland
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 203.0 -3.72 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Achieve Life Sciences Achieve Life Sciences
ACHV
$ 4.64 -0.32 % $ 92 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.36 2.73 % $ 8.08 B Nasdaq Capital Market australiaAustralia
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$ 3.29 -1.5 % $ 908 M Nasdaq Capital Market israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
$ 54.27 -1.38 % $ 10.3 B Nasdaq Global Select Market,SPB usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Baudax Bio Baudax Bio
BXRX
- 0.59 % $ 63 K Nasdaq Capital Market usaUSA
AbbVie AbbVie
ABBV
$ 224.99 -0.01 % $ 398 B NYSE,SPB usaUSA
Cara Therapeutics Cara Therapeutics
CARA
- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
ChemoCentryx ChemoCentryx
CCXI
- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
BioNTech SE BioNTech SE
BNTX
$ 96.22 -1.21 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Codiak BioSciences Codiak BioSciences
CDAK
- -55.98 % $ 2.15 M Nasdaq Global Market usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
$ 18.75 -0.48 % $ 2.76 B Nasdaq Global Select Market,SPB usaUSA
Avid Bioservices Avid Bioservices
CDMO
- - $ 789 M Nasdaq Capital Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
$ 1.92 -7.01 % $ 4.87 M Nasdaq Global Select Market,SPB usaUSA
Biogen Biogen
BIIB
$ 179.76 1.11 % $ 26.2 B Nasdaq Global Select Market,SPB usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
- - $ 7.29 B Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
$ 23.52 -2.22 % $ 1.94 B Nasdaq Global Select Market usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
$ 3.45 -0.72 % $ 1.02 B Nasdaq Global Select Market canadaCanada
Cabaletta Bio Cabaletta Bio
CABA
$ 2.37 -2.67 % $ 2.77 M Nasdaq Global Select Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
- - $ 25.3 M Nasdaq Global Market usaUSA
Celsion Corporation Celsion Corporation
CLSN
- -6.63 % $ 13.9 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
- - $ 231 M Nasdaq Global Market usaUSA
Chimerix Chimerix
CMRX
- - $ 756 M Nasdaq Global Select Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
- - $ 401 M Nasdaq Global Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.